Harrow (NASDAQ: HROW) insider transactions
In the twelve months to 10 November 2026, executives and directors of Harrow reported 7 open-market sales of 234,822 shares ($9.6m) and 4 open-market purchases of 15,500 shares ($468,720), by 6 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 14 August 2026 | Shojaei Amir | Chief Scientific Officer | Option exercise | +11,250 | $35.96 | 11,250 | Form 4 |
| 14 August 2026 | Shojaei Amir | Chief Scientific Officer | Open-market sale | −11,250 | $40.00 | 0 | Form 4 |
| 18 May 2026 | Silvernail Lauren P | Director | Open-market purchase | +1,000 | $31.00 | 1,000 | Form 4 |
| 18 May 2026 | Graves Adrienne L | Director | Open-market purchase | +1,000 | $31.07 | 1,000 | Form 4 |
| 14 May 2026 | Boll Andrew R. | President and CFO | Open-market purchase | +3,500 | $29.90 | 814,679 | Form 4 |
| 14 May 2026 | Baum Mark L | Chief Executive Officer | Open-market purchase | +10,000 | $30.20 | 2,996,130 | Form 4 |
| 4 March 2026 | Opaleye Management Inc. | — | Open-market sale | −134,000 | $39.67 | 3,622,000 | Form 4 |
| 4 March 2026 | Opaleye Management Inc. | — | Open-market sale | −4,263 | $39.67 | 59,428 | Form 4 |
| 3 March 2026 | Opaleye Management Inc. | — | Open-market sale | −59,000 | $39.15 | 3,756,000 | Form 4 |
| 3 March 2026 | Opaleye Management Inc. | — | Open-market sale | −1,309 | $39.15 | 63,691 | Form 4 |
| 27 February 2026 | Opaleye Management Inc. | — | Open-market sale | −5,000 | $54.18 | 65,000 | Form 4 |
| 6 January 2026 | Opaleye Management Inc. | — | Open-market sale | −20,000 | $53.35 | 70,000 | Form 4 |
| 12 December 2025 | Baum Mark L | Chief Executive Officer | Option exercise | +180,000 | $3.95 | 3,066,124 | Form 4 |
| 12 December 2025 | Baum Mark L | Chief Executive Officer | Shares withheld for tax | −79,994 | $47.06 | 2,986,130 | Form 4 |
| 12 December 2025 | Boll Andrew R. | President and CFO | Option exercise | +60,000 | $3.95 | 837,844 | Form 4 |
| 12 December 2025 | Boll Andrew R. | President and CFO | Shares withheld for tax | −26,665 | $47.06 | 811,179 | Form 4 |
| 21 July 2025 | Baum Mark L | Chief Executive Officer | Option exercise | +600,000 | $7.87 | 3,199,462 | Form 4 |
| 21 July 2025 | Baum Mark L | Chief Executive Officer | Shares withheld for tax | −313,338 | $37.08 | 2,886,124 | Form 4 |
| 10 June 2025 | Opaleye Management Inc. | — | Open-market sale | −15,000 | $30.80 | 90,000 | Form 4 |
| 9 June 2025 | Opaleye Management Inc. | — | Open-market sale | −15,204 | $30.37 | 105,000 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Harrow page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.